Similar Posts
Antibody Tests Could Offer A False Sense of Security
A lot of hope on reopening businesses and returning to work in the U.S. hinges on COVID-19 testing and the development of treatments and a vaccine. But as the country ramps up antibody testing – analyzing blood samples for signs someone has been exposed to or infected with the coronavirus that causes COVID-19 – physician…
Here’s Why Pharmaceutical Companies Raise Their Prices So Much
Yes, I’ve ranted about healthcare prices before. On more than one occasion. But I have a new rant for you. It’s not about the high price of new drugs It’s not about a couple pharmo-bro CEOs hiking prices of generic medications by 4 or 5,000% It’s about brand name drugs already on the market, that,…
Critics Wonder Whether the FDA Is Too Slow to Handle a Pandemic
The FDA plays a critical role in our nation’s response to the COVID-19 pandemic. It helps decide which medicines are safe and effective to treat the disease. It evaluates the accuracy and reliability of laboratory tests. And it will play a central role in assessing potential vaccines. But will the FDA bureaucracy move with the…
Medicare Pays More Money To Doctors Taking Care Of Rich Patients. Here’s Why.
It has always been financially rewarding for doctors to take care of rich patients. People with more money…well, they have more money to spend on healthcare. But shouldn’t this more money/higher payment relationship go away in Medicare? It doesn’t, and some recent payment reforms may be making matters worse. (To read the rest of the…
The Verdict Is In—Price Gouging Harms People With Gout
The patient arrived in my clinic, their right big toe the color of a spring strawberry. The lightest touch caused exquisite pain. Fortunately, I was able to prescribe a pill (an ancient medicine, actually) and the patient was better by the next day.
Too bad that simple treatment is becoming unaffordable, through a maddening combination of greed and regulatory failure.
